Back to CVE records
High 7.8Published Oct 9, 2026

CVE-2026-92705Aegisub executes arbitrary code through automatically loaded Automation scripts

Updated under an hour ago ()

Does this affect you?

It affects TypesettingTools Aegisub. Add what you run to find out whether that includes you.

EPSS puts the chance of exploitation in the next 30 days at 0.13%, higher than 2% of scored CVEs.

Aegisub is a cross-platform advanced subtitle editor. From 3.2.0 to 3.4.2, Aegisub automatically loads Automation scripts referenced by `Automation Scripts` metadata in `ASS` subtitle projects without asking whether the user trusts the scripts or their authors. An attacker can distribute a crafted `ASS` file together with a referenced malicious Automation script, and opening the `AS`  file executes arbitrary code with the privileges of the Aegisub process. From 3.4.0 to 3.4.2, inconsistent handling of embedded `NUL` characters between extension validation and filesystem operations additionally allows a crafted `ASS/Lua` polyglot to reference and execute itself as a single-file variant. The vulnerability is fixed in Aegisub 3.5.0.

CVSS
7.8 HIGH (v3.1, CNA)CVSS:3.1/AV:L/AC:L/PR:N/UI:R/S:U/C:H/I:H/A:H
Weakness (CWE)
CWE-158, CWE-829
Known exploited
Not in CISA's KEV catalog
EPSS (exploitation in the next 30 days)
0.13% (percentile 2)
Assigned by
GitHub_M
NVD analysis
Deferred
Record last updated
Oct 14, 2026
First seen by InfoSec Signals
Oct 9, 2026

Affected products

Affected products
TypesettingTools Aegisub
typesettingtools:aegisub (from the name)
from 3.2.0, < 3.5.0
CNA record

References

  • x-refsource-confirm
  • x-refsource-misc
  • x-refsource-misc
  • x-refsource-misc

The CVE record is authoritative. Products marked “from the name” were identified from the CNA's free-text names, not a CPE, and are matched less certainly. This product uses the NVD API but is not endorsed or certified by the NVD.

Your cookie choices
We use essential cookies to run this site, and, only with your consent, an advertising cookie from Google to measure whether our ads lead to sign-ups and subscriptions. See our for details.